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AbstrAct
Introduction Many studies have indicated the impact of 
bias in dissemination and publication in medical research. 
Existence of such bias among clinical trials has been 
repeatedly pointed out, but it has not been well studied in 
the field of systematic reviews (SRs). We therefore aim to 
investigate whether or not time lag bias and publication 
bias in SRs based on statistical significance in results 
exist. In addition, we will examine at what stage of paper 
publication process such bias, if any, creeps in.
Method and analysis The present study is a meta-
epidemiological study. We will include all SRs of 
interventions registered in the international prospective 
register of SRs (PROSPERO) before December 2014 
if the SR has completed its analysis irrespective of its 
publication status. All contact authors of eligible SRs 
will be asked to participate in a survey administered 
through the Internet. Our primary outcome is time from 
protocol registration to full publication of SR as a journal 
article, defined as time from the registration date to the 
acceptance date among all the relevant SRs. We will 
examine the impact of statistically significant findings on 
the primary outcomes through time to event analyses.
Ethics and dissemination Ethics approval will be 
obtained from the Ethical Committee of the Kyoto 
University Graduate School of Medicine. This protocol 
has been registered in the University Hospital Medical 
Information Network Clinical Trials Registry. We will publish 
our findings in a peer-reviewed journal and also may 
present them at conferences. Trial registration number: 
UMIN000028325
IntroductIon
Many studies have reported bias in dissemina-
tion and publication of research findings in 
medicine.1–5 Bias in dissemination and publi-
cation can be introduced at all stages of the 
publication process after study commence-
ment, such as conducting research and writing 
up of manuscripts by investigators, and accep-
tance by journal editors or peer reviewers.
Publication bias occurs when the authors’ 
decision to write and submit the results or 
editors’ acceptance for publication is influ-
enced by the direction or strength of the 
study findings.6 When this happens, find-
ings of published studies will be systemati-
cally different from those of unpublished 
studies and hence from the underlying truth 
(figure 1).7
Time lag bias is one aspect of publication 
bias which arises when the speed of publica-
tion depends on the direction and nature of 
the results.2 7 8 In randomised clinical trials 
(RCTs), trials without statistically significant 
results take a longer time before publica-
tion than trials with statistically significant 
results (figure 1).4 Prior studies found that 
publication bias is often due to investigators’ 
failure to write up and submit rather than 
due to editors or reviewers.7 9 With respect to 
time lag in particular, one can characterise 
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Protocol
strengths and limitations of this study
 ► This is the first study to contact the authors 
of unpublished systematic reviews (SRs) and 
investigate the existence and the magnitude of time 
lag bias in the realm of SRs.
 ► The factors associated with time to publication of 
SRs will inform potential preventive measures for 
these biases.
 ► The generalisability will be limited because the 
analyses investigating the biases include only those 
who registered the protocol in the PROSPERO and 
responded to our survey.
 ► The time to publication may not reflect true time lag 
bias that is the period between the initiation of the 
SR and its publication because protocols may be 
registered after their analyses
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Figure 1 Concept of the present study. Study with 
statistically significant findings may be more likely to be 
submitted, accepted and published (publication bias) and 
published earlier (time lag bias).
the phenomenon as either delay due to non-significant 
results, or expedited submission and publication due to 
significant results.
Bias in dissemination and publication among clinical 
trials has been well studied; however, it has not been 
much studied in the field of non-Cochrane systematic 
reviews (SRs).10 A study suggested that statistically signif-
icant results were not associated with time to publication 
of Cochrane reviews.11 This result may not apply non-Co-
chrane reviews because several studies suggested that 
there was deference in the quality of reporting between 
Cochrane and non-Cochrane reviews.12 13 A survey among 
first or corresponding authors of SRs indicated that 
unpublished SRs exist.14 The authors reported common 
reasons for not publishing SRs including lack of time 
and the manuscript being rejected by journals. Statistical 
significance was not reported as being a major barrier 
or reason for not publishing, but 65% of respondents 
reported significant results as a significant facilitator for 
publishing SRs—in other words, authors are more likely, 
faced with other pressures, to take the time to complete 
and submit their review when they have positive results to 
report. Moreover, non-Cochrane SRs were likely to report 
statistically significant findings and positive conclusions.13 
We recently reported that more than 30% of non-Co-
chrane SRs registered in the international prospective 
register of SRs (PROSPERO) were not published after at 
least 50 months of registration.15 These results indicate 
that time lag bias and publication bias among non-Co-
chrane SRs may well exist.
This study therefore aims to investigate whether or not 
time lag bias and publication bias in SRs based on statis-
tical significance exist. We will also evaluate other factors 
associated with time to publication.
objEctIvEs
We aim to evaluate the association between statistical 
significance of meta-analysis result and publication status 
using a number of criteria (full publication in a journal 
article, submission to any journals, presentation of an 
abstract at a meeting) among SRs. We also aim to examine 
other factors of possible influence and publication of SRs.
MEthods And AnAlysIs
Inclusion and exclusion criteria
All SR protocols of interventions registered in the PROS-
PERO by 31 December 2014 will be eligible. We have 
chosen this time limit because we expect that it may often 
take 3 years to complete and publish SR after its regis-
tration.15 We will exclude SRs that include studies other 
than RCT. We will exclude SRs whose analysis has not 
been completed and SRs without quantitative synthesis. 
We will exclude Cochrane protocols and reviews because 
their publication process is different from general 
peer-reviewed journals. We will also exclude SRs of diag-
nostic test accuracy and prognosis, and SRs with network 
meta-analysis, individual patient data meta-analyses 
because different factors are likely to be at play. figure 2 
shows the expected flow diagram of this study.
search method
We will search the relevant SRs in the PROSPERO. The 
planned start date of the search will be on 15 November 
2017. We will use search filters of ‘Exclude Cochrane 
protocols’ for type of protocol and ‘Intervention, Preven-
tion or Service Delivery’ for type and method of the 
review. For protocols with ‘Ongoing and Completed’ 
stage of review, we will search MEDLINE via PubMed 
and Google Scholar to find a full publication, using the 
authors’ names and the keywords for participants or 
intervention in the PROSPERO because our pilot search 
indicated the status of the PROSPERO may often not be 
updated promptly to reflect the true status. For protocols 
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Figure 2 Expected flow diagram of the present study. RCT, randomised clinical trials; SRs, systematic reviews.
with ‘Abandoned’ stage of review, we will exclude them 
when their data analyses have not been completed.
study selection
The selected studies based on a random sample of 500 of 
the PROSPERO records identified by the initial search 
will be divided into two subsamples of 250, and two pairs 
of assessors (YTsuj-YTsut and HT-YK) will assess the eligi-
bility for each set separately. We will resolve disagree-
ments by discussion between the authors, with another 
author (TAF) acting as an arbiter.
data extraction
All records of included SR protocols will be downloaded 
from the PROSPERO for the use of data extraction. Four 
authors (YTsuj, YTsut, DP and YK) will independently 
extract the following data from the relevant SRs in the 
PROSPERO: Registration and anticipated date of comple-
tion, the number of authors, funding sources, conflicts 
of interests (COIs), stage of review, year of registration 
and countries where the study has been conducted. We 
will define the primary review question of the SR in terms 
of participant, intervention, comparator and primary 
outcome. As the review may provide several comparisons 
for the same class of interventions and comparators, we 
will define the primary comparison as the intervention 
and comparator that are described as the primary or the 
first one in the intervention and comparator section in 
the PROSPERO record, and the primary outcomes as 
all outcomes listed in the primary outcome section of 
PROSPERO. If the primary outcome was analysed for 
multiple time points, we will use the meta-analysis result 
that included the largest number of studies. Should the 
primary outcome be missing in the primary outcome 
section of PROSPERO, we will define the one mentioned 
first as the primary outcome. For SRs published in a 
journal article, we will extract the date of acceptance. 
We choose acceptance date rather than publication 
date because the interval between acceptance date and 
publication date depends on many external factors unre-
lated to publication bias. If acceptance date is not avail-
able, we will use the publication date for SRs published in 
open access journals, and the date of online publication 
ahead of print for SRs published in other journals. We will 
contact the authors or the editorial office if the relevant 
date is missing.
survey
For potentially eligible SRs, we will contact the authors 
listed in the ‘Contact details for further information’ of 
the PROSPERO records and will ask them to respond 
to a survey through the internet. Through the survey, 
all contact authors of potentially eligible unpublished 
SRs will be asked whether or not the SR analysis has 
been completed. Additionally, all contact authors of 
published or completed but not published SRs will be 
asked the following information: whether or not each 
of the primary outcomes in the primary comparison (as 
defined by a decision rule described in Data extraction 
section above) was statistically significant; the review 
team’s involvement in any of the trials included in the 
SR; the author’s experience to publish an SR as a lead 
author before the PROPERO registration; relationship 
with a private for-profit consulting firm for SRs; and 
main barriers to publish the SR according to a classifi-
cation used in a previous study.14 In addition, we will ask 
if someone has published a review addressing the same 
question. If the authors have completed the analysis but 
not published it, the following information will be sought: 
the number of included trials in the SR; whether or not 
they have presented the SR at a scientific conference; 
and whether or not they have submitted the SR to any 
journals. All surveys will be administered using Google 
Form (https://www. google. com/ intl/ en/ forms/ about). 
We will send a reminder along with the Google form link 
1 week after the initial contact. If the authors have not 
responded by that time, we will repeat this process twice.
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sample size
Based on previous findings, we estimate that proportion 
of statistical significance is approximately 50% among 
SRs registered in the PROSPERO, and the median time 
to publication are 15 months for SRs with statistical signif-
icance and 25 months for SRs without statistical signifi-
cance.7 13 15 16 A total of 110 events is expected to provide 
approximately 90% power to detect the difference with 
an assumed type I error of 0.05 (two-sided). Assuming 
that approximately 50% of the eligible protocols are not 
published, we would need a total of 220 SRs. We aim to 
repeat the random sampling of relevant SRs from PROS-
PERO until the number of eligible SRs whose authors 
respond to our survey reaches 220, or the registry is 
exhausted. The sample size will be modified when the 
actual proportion of unpublished reviews among the 
eligible protocols in our first batch is less than 30% or 
more than 70%.
data analysis
Primary analyses
Our primary outcome is (1) time from protocol registra-
tion to publication of SRs in journal articles, defined as 
time (months) from the registration date to the accep-
tance date. We will draw Kaplan-Meier curves for time to 
publication, classified by SRs with and without statistically 
significant meta-analysis results. We will examine the asso-
ciation of statistical significance and time to publication 
using Log-rank test. We will then use Cox proportional 
hazard model for a multivariable analysis to adjust for two 
apparent confounders, namely the number of included 
studies and year of registration. The number of included 
studies possibly associates with the importance of the 
topic, and the increase of statistical power. The year of 
registration may associate with the effect size of the inter-
vention, and the acceptance rate of SRs.
Secondary analyses
Secondary outcomes will include (2) proportion of SR 
published in journal articles, (3) a composite outcome of 
full publication or presentation at scientific conferences 
and (4) submission to any journals. We will describe a 
table showing the proportion of statistical significance 
and summarise the characteristics of included SRs clas-
sified by full publication, submission, presentation and 
no dissemination. We will analyse the association between 
statistically significant findings and the secondary 
outcomes using univariable logistic regression, and multi-
variable logistic regression to adjust for the number of 
included studies and year of registration.
When there is a statistically significant association 
between statistically significant findings and time to 
publication, we will explore the predictors of time to 
publication other than statistical significance, number 
of included studies and year of publication. First, we will 
examine the association of the proportion or time to 
publication with academic or financial COI, experience 
of SR publication, country of contact author’s affiliation 
(English speaking or not) or multinational collaboration 
using Log-rank test. Then, we will use Cox proportional 
hazard model to explore the influence of these factors on 
the association between statistical significance and time 
to publication. We will summarise proportion of SRs that 
have not reported the primary outcomes as defined in the 
protocol among published SRs. We will describe whether 
or not the PROSPERO status reflect the true publication 
status and will summarise the barriers for completed SRs 
to publish.
Continuous variables will be shown as mean (stan-
dardised deviation) and categorical variables will be 
expressed as numbers with percentage (%). A two-sided 
p value smaller than 0.05 will be considered statistical 
significance. We will use Stata/SE, V.14.0 (StataCorp, 
College Station, TexasX, USA) for all analyses.
Sensitivity analysis
We will conduct the following prespecified sensitivity 
analysis: Restricting SRs to those in which the authors 
have clearly predefined primary outcomes including the 
time point of measurement in their protocols
EthIcs And dIssEMInAtIon
Ethics approval will be obtained from the Ethical 
Committee of the Kyoto University Graduate School of 
Medicine. This protocol has been registered in the Univer-
sity Hospital Medical Information Network (UMIN) 
Clinical Trials Registry (Trial registration number: 
UMIN000028325). The planned completion date of the 
present study is 31 December 2018. We will publish our 
findings in a peer-reviewed journal and also may present 
them at conferences.
dIscussIon
SRs with adequate quality have potentials to alter the daily 
clinical practice, and are useful resources in developing 
clinical practice guidelines and policies. Time lag bias 
and publication bias can be a strong barrier to research 
transparency and integrity. Before the launch of PROS-
PERO, it was difficult to find SR protocols that remained 
unpublished. After 6 years from its launch, the registry will 
enable us to evaluate publication bias and time lag bias in 
the SR field, as was the case of clinical trial registries.7 
This is the first study to contact the authors of unpub-
lished SRs and investigate the existence and the magni-
tude of these biases. We recently suggested that protocol 
registration was not associated with reporting of statistical 
significance.16 The factors associated with publication or 
time to publication of SRs will inform potential preven-
tive measures for these biases. We also aim to describe the 
publication rate of registered protocols and the propor-
tion of published SRs that have not reported primary 
outcomes as defined in the protocol, and check whether 
the PROSPERO status reflects the true publication status.
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There are several expected limitations for this study. 
First, the generalisability will be limited because the 
analyses investigating the biases include only those who 
registered the protocol in the PROSPERO and respond 
to our survey. In order to increase the response rate, we 
will remind the contact authors up to two times for every 
week if they do not respond to our survey. Second, the 
time to publication may not reflect true time lag bias 
that is the period between the initiation of the SR and 
its publication because protocols may be registered after 
their analyses. The PROSPERO prohibits registration of 
completed reviews but some may nonetheless register 
after the completion of the analysis.17 Because SRs that 
registered after their completion are more likely to have 
statistically significant findings and may be published 
earlier, if there are many such protocols, our hypothe-
sised association may be overestimated. Third, there can 
be unmeasurable confounding such as the methodolog-
ical quality of the protocol. We will therefore perform 
a sensitivity analysis to restrict studies that adequately 
predefined their primary outcomes. Fourth, the accuracy 
of PROSPERO filters is unknown, but the use of these 
filters is not likely to bias the results of the present study. 
Finally, unlike clinical trials, the authors may not intend 
to find statistical significance in the realm of SRs. This 
may bias the association between statistical significance 
and publication towards null.
In conclusion, this study will provide comprehensive 
investigation about time lag bias and publication bias in 
the realm of SRs using the first global registry for SRs.18 
The expected findings will show the needs and the key 
factors to prevent such biases.
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